SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony@Pacific who wrote (19317)3/10/1999 6:10:00 PM
From: Cube  Read Replies (1) of 122087
 
IMCL, I'm not even very skeptical Anthony. You can't get to phase 3 from 2 on any trumped up or BS results. FDA knows the difference between rodentcide and complete elimination of tumor in 88% of human subjects. FDA looked at the results and immediately granted them a phase 3 application. CNBC also talked about a "possibility" of something called sympathetic progress(I think that was the term) which means if results in phase 3 continue with this high of a percentage, they'll approve it for use in terminal patients before phase 3 is even concluded. I know anything can happen, but I really like this one.

Cube
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext